Publications
Current Publications:
Wood JP, Silveira JR, Maille NM, Haynes LM, Tracy PB (2011) Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity. Blood 117(5): 1710-8.
Regis L, Souza WV, Furtado AF, Fonseca CD, Silveira Jr JC, Ribeiro Jr PJ, Melo-Santos MA, Carvalho MS, Monteiro AM (2009) An entomological surveillance system based on open spatial information for participative dengue control. An Acad Bras Cienc 81(4): 655-62.
Silveira JR, Hughson AG, Caughey B (2006) Fractionation of prion protein aggregates by asymmetrical flow field-flow fractionation. Methods Enzymol 412: 21-33.
Caughey B, Caughey WS, Kocisko DA, Lee KS, Silveira JR, Morrey JD (2006) Prions and transmissible spongiform encephalopathy (TSE) chemotherapeutics: A common mechanism for anti-TSE compounds? Acc Chem Res 39(9): 646-53.
Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B (2005) The most infectious prion protein particles. Nature 437(7056): 257-61.
Sánchez RM, Sierra AP, Obregón Fuentes AM, González IR, Gil AB, Suárez MB, Silveira JR, Gastón BD (2002) [Reactogenecity and immunogenecity of Cuban trivalent inactivated vaccine against human leptospirosis in different vaccination schedules]. Rev Cubana Med Trop 54(1): 37-43.
Gould WR, Simioni P, Silveira JR, Tormene D, Kalafatis M, Tracy PB (2005) Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost 3(3): 450-6.
Faculty Highlighted Publications:
Wood, J., Silveira, J., Maille, N., Haynes, L., and Tracy, P. Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity. Blood. 2011 Feb 3;117(5):1710-8.
DeMarco, M., Silveira, J., Caughey, B., and Daggett, V. Structural properties of prion protein protofibrils and fibrils: An experimental assessment of atomic models. Biochemistry 45:15573-15582, 2006.
Gould, W., Simioni, P., Silveira, J., Tormene, D., Kalafatis, M., and Tracy, P. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. Journal of Thrombosis and Haemostasis 3(3):450-456, 2005.
Silveira J., Raymond G., Hughson A., Race R., Sim V., Hayes S., and Caughey B. The most infectious prion protein particles. Nature 437:257-261, 2005.
* indicates equal contribution
